Literature DB >> 1722396

Growth signal erythropoietin activates the same tyrosine kinases as interleukin 3, but activates only one tyrosine kinase as differentiation signal.

S Kuramochi1, T Chiba, H Amanuma, A Tojo, K Todokoro.   

Abstract

By Western blotting with anti-phosphotyrosine-specific antibody, we demonstrated that both erythropoietin (Epo) and interleukin 3 (IL3) induce rapid and transient tyrosine phosphorylation of a common set of proteins of 45, 55, 69, 87, 90, 95 and 160 KDa as a growth signal in Epo- and IL3-dependent FD-M6 cells. In contrast, only two proteins of 87 and 90 KDa were transiently phosphorylated in Epo-induced erythroid differentiation of SKT6 cells. Furthermore, no tyrosine phosphorylation was observed in dimethyl sulfoxide-induced differentiation of SKT6 cells. Taken together with other observations, these results indicate that Epo, IL3 and GM-CSF activate the same tyrosine protein kinases as growth signal and that Epo-induced differentiation signal uses only a part of the tyrosine kinase pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722396     DOI: 10.1016/0006-291x(91)92052-l

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia.

Authors:  J L Nichol; M M Hokom; A Hornkohl; W P Sheridan; H Ohashi; T Kato; Y S Li; T D Bartley; E Choi; J Bogenberger
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

2.  Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.

Authors:  A Dubart; F Feger; C Lacout; F Goncalves; W Vainchenker; D Dumenil
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.